皮膚科用藥 的英文怎麼說

中文拼音 [pífūkēyòngyào]
皮膚科用藥 英文
dermatologix agent
  • 皮 : Ⅰ名詞1 （人或物體表面的一層組織） skin 2 （皮革） leather; hide 3 （毛皮） fur 4 （包在外面的一層...
  • 膚 : 名詞（皮膚） skin
  • 科 : Ⅰ名詞1 （學術或業務的類別） a branch of academic or vocational study 2 （機關按工作性質而分設的單...
  • 用 : Ⅰ動詞1 （使用） use; employ; apply 2 （多用於否定: 需要） need 3 （敬辭: 吃; 喝） eat; drink Ⅱ名...
  • 藥 : Ⅰ名詞1 （藥物） medicine; drug; remedy 2 （某些有化學作用的物質） certain chemicals Ⅱ動詞1 [書面...
  • 皮膚科 : [醫學] dermatological department; dermatology
  • 皮膚 : skin; baragnosis; derma; hide
  • 用藥 : administer drugs
  1. Purpose : to explore the risk factors for nosocomial infection of urological surgical department. method : 2 976 cases of urological surgical patients was investigated retrospectively for the nosocomial infective prevalence in urological surgical department from the april 1996 to april 1999. result : nosocomial ratio in urological surgical department was 4. 87 %, in which 73. 1 % for male and 26. 9 % for female. the infective sites are lower respiratory tract, surgical wound, urinary tract, gastrointestinal tract, upper respiratory tract and skin - soft tissues in turn, infection rates were 4. 38 %, 10. 4 %, 13. 6 %, 27. 6 %, 25. 5 %, 30. 3 %, 20. 8 %, 42. 6 % for clean wound, dirty wound, infection wound, artery catheter, venouse catheter, urinary tract catheter, respiratory tract, and general anesthesia respectively. conclusion : the nosocomial infection was not related to age, infection time and the usage of antibiotics ; but was closely related to gender, surgical sites, surgical wound type, invasive operation, the degree of tisk index and micropathogens

    目的:探討泌尿外科醫院感染的危險因素.方法:回顧性調查1996年4月1999年4月間我院泌尿外科手術患者2976例的醫院感染情況.結果:泌尿外科醫院感染率為4 . 87 % ，其中男性佔73 . 1 % ，女性佔26 . 9 % ;感染部位依次為下呼吸道、手術傷口、泌尿道、胃腸道、上呼吸道、皮膚軟組織;類切口術后感染率為4 . 4 % ，類切口術后感染率為10 . 4 % ，類切口術后感染率為13 . 6 % ;動脈插管感染率為27 . 6 % ，靜脈插管感染率為25 . 5 % ，泌尿道插管感染率為30 . 3 % ，呼吸道感染率為20 . 8 % ，全麻感染率為42 . 6 % .結論:醫院感染與患者年齡、感染時間和抗菌藥物使用情況無關，與性別、部位分佈、手術切口類型、侵入性操作、危險指數等級及病原微生物有密切關系
  2. Abstract : purpose : to explore the risk factors for nosocomial infection of urological surgical department. method : 2 976 cases of urological surgical patients was investigated retrospectively for the nosocomial infective prevalence in urological surgical department from the april 1996 to april 1999. result : nosocomial ratio in urological surgical department was 4. 87 %, in which 73. 1 % for male and 26. 9 % for female. the infective sites are lower respiratory tract, surgical wound, urinary tract, gastrointestinal tract, upper respiratory tract and skin - soft tissues in turn, infection rates were 4. 38 %, 10. 4 %, 13. 6 %, 27. 6 %, 25. 5 %, 30. 3 %, 20. 8 %, 42. 6 % for clean wound, dirty wound, infection wound, artery catheter, venouse catheter, urinary tract catheter, respiratory tract, and general anesthesia respectively. conclusion : the nosocomial infection was not related to age, infection time and the usage of antibiotics ; but was closely related to gender, surgical sites, surgical wound type, invasive operation, the degree of tisk index and micropathogens

    文摘:目的:探討泌尿外科醫院感染的危險因素.方法:回顧性調查1996年4月1999年4月間我院泌尿外科手術患者2976例的醫院感染情況.結果:泌尿外科醫院感染率為4 . 87 % ，其中男性佔73 . 1 % ，女性佔26 . 9 % ;感染部位依次為下呼吸道、手術傷口、泌尿道、胃腸道、上呼吸道、皮膚軟組織;類切口術后感染率為4 . 4 % ，類切口術后感染率為10 . 4 % ，類切口術后感染率為13 . 6 % ;動脈插管感染率為27 . 6 % ，靜脈插管感染率為25 . 5 % ，泌尿道插管感染率為30 . 3 % ，呼吸道感染率為20 . 8 % ，全麻感染率為42 . 6 % .結論:醫院感染與患者年齡、感染時間和抗菌藥物使用情況無關，與性別、部位分佈、手術切口類型、侵入性操作、危險指數等級及病原微生物有密切關系
  3. Pvp - i is from coming out to the present, the scientists of various countries prepare, the research of form of a drug, structure analysis, research of pharmacology, toxicity, medicine supersession, sterilization mechanism and dynamics through chemistry, is it have pvp - i only to be security most high to prove, recognize as at supporting clinical only using as human skin disinfectant of mucous membrane extensively

    Pvp - i從問世至今，各國科學家通過化學制備、劑型研究、結構分析、藥理、毒理、藥物代謝、殺菌機制及其動力學的研究，證明唯有pvp - i安全性最高，公認為唯一可供臨床上廣泛用作人體皮膚粘膜的消毒劑。
  4. Bullosa epidermolysis necrosis drug eruption is one type of most serious drup eruption and the mortality rate of the patients is high, in our department, 15 cases of patients with bullosa epidermolysis necrosis drug eruption were cured with the adjunctive therapy of high dose of intravenous immunoglobulin ( hdivig ) ; to these patients, earlier, timely and effective therapy and nursing measure such as intensive nursing of skin and mucosa, strict sterilization and isolation were very important

    大皰表皮鬆解壞死型藥疹是最嚴重的藥疹之一，死亡率高，我科對15例大皰表皮鬆解型藥疹應用大劑量免疫球蛋白輔助治療全部治愈;對此類患者，早期及時而有效地治療和加強皮膚粘膜的護理以及嚴格的消毒隔離等護理措施至關重要。
  5. Dr. craig elmets is a dermatologist at uab. " these patients are placed on immunosuppressive medications and by suppressing the immune system it accelerates the development of cancer.

    Craig elmets是uab的一位皮膚科醫生，他講到「那些病人使用免疫抑制藥物，使得免疫功能被削弱導致癌癥發展加速。
  6. Professional consultation for skin drugs ; professional disposition for demartological hospital ; diagnosis and treatment for skin diseases and std ; dermatopathological diagnosis and research for skin diseases

    皮膚科用藥的專業咨詢；皮膚病醫院的專業配置；皮膚病性病診斷治療；皮膚病理診斷研究。
  7. Diagnosis and treatment of skin disease and std, especial in cutaneous hemangioma, condylom acuminatum and photodermatosis. development and utilization of the medicine and instrument in dermatology

    皮膚病與性病診斷與治療，尤其是皮膚血管瘤、尖銳濕疣及光敏性皮膚病。皮膚科用藥及治療儀器的開發與利用。
  8. Advanced time - released technology delivers the most powerful dermatologist - preferred acne - healing medicine available without a prescription - - effective even where traditional prescription and over the counter treatments have failed

    先進的time - released （持續作用）科技傳遞最有效的、最為皮膚專家所稱道的、市面上可以在櫃臺上直接買到、無須配方的治療粉刺的藥物。
  9. Guangzhou keni cosmetics companyltd. has been engaged in professional beauty for ten years, and diligently striven after the applications that the traditional chinese me - dical sciencd has in modern medical beauty. its products especially effective in curing various trouble skins are distinctive and wess received in the fideld of cosmetics

    廣州科妮化妝品有限公司致力於專業美容已有十年歷程，孜孜以求于中醫藥科學在現代醫學美容中的應用，尤其是針對各種問題性皮膚的特效產品在美容界獨樹一幟備受好評。
分享友人
分享到 Line

分享到臉書